scholarly journals A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma

2018 ◽  
Vol 38 (5) ◽  
Keyword(s):  
Prostate Cancer ◽  
Renal Cell Carcinoma ◽  
Bone Metastasis ◽  
Urothelial Carcinoma ◽  
Cell Carcinoma ◽  
Retrospective Analysis ◽  
Renal Cell ◽  
Scoring System ◽  
Genitourinary Cancer ◽  
Prediction Of Survival

Clinical features and outcomes of tumor lysis syndrome in patients with genitourinary cancers.

2019 ◽  
Vol 37 (7_suppl) ◽  
pp. 533-533
Author(s):  
Jue Wang ◽  
Bryan Leung
Keyword(s):  
Prostate Cancer ◽  
Renal Cell Carcinoma ◽  
Liver Metastasis ◽  
Urothelial Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Features ◽  
Renal Cell ◽  
Tumor Lysis Syndrome ◽  
Tumor Lysis ◽  
Genitourinary Cancers

533 Background: Genitourinary (GU) cancers account about 20% of all human cancer in the United States. Tumor lysis syndrome (TLS) is an oncologic emergency with few treatment options. While TLS has been extensively documented in patients with hematological malignancies, it is rarely described in patients with GU cancers. The objective of this study was to investigate the clinical characteristics and outcomes of TLS, a rare but life-threatening complication in GU cancers. Methods: Systematic review of the literature and pooled analysis of published cases of TLS in GU cancers. Results: A total of 180 patients with TLS in solid tumor were included in our study. The median age was 57 years (8-94). Male: female ratio was 1.7. The most common sites were gastrointestinal (29%); followed by genitourinary (22%); lung (16%); melanoma (11%), breast cancer (8.3%). Liver metastasis was documented in 70% of study subjects. TLS occurred as a consequence of cancer therapy in 68% of subjects; and spontaneously in 32% of subjects. Older age and liver metastasis predict high mortality. The clinical features, treatment and outcomes of TLS in 40 cases of GU cancers including testicular germ cell tumor (TGCT) (n=14), renal cell carcinoma (n=10), prostate cancer (n=15), penile cancer (n=1) and urothelial carcinoma (n=3) were compared. The mortality rate of TLS were 50% in TGCT, 70% in renal cell carcinoma, 64% in prostate cancer 67% in urothelial carcinoma. Conclusions: TLS in GU cancers is associated with very high mortality. TLS should be considered on the differential diagnosis, when evaluating renal failure and electrolyte derangement in patients with metastatic GU cancers with liver metastases. The clinical features and outcomes of TLS in genitourinary cancers. [Table: see text]

264: Population-Based Study of Renal Cell Carcinoma and Prostate Cancer in the Same Patient

2005 ◽  
Vol 173 (4S) ◽  
pp. 73-73 ◽  
Author(s):  
Daniel A. Barocas ◽  
Farhang Rabbani ◽  
Douglas S. Scherr ◽  
E. Darracott Vaughan
Keyword(s):  
Prostate Cancer ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Population Based ◽  
Population Based Study

scholarly journals Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

2021 ◽  
pp. 100393
Author(s):  
Dylan J. Martini ◽  
Meredith R. Kline ◽  
Yuan Liu ◽  
Julie M. Shabto ◽  
Bradley C. Carthon ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Scoring System ◽  
Risk Scoring ◽  
Risk Scoring System

18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma

2014 ◽  
Vol 35 (12) ◽  
pp. 1247-1253 ◽  
Author(s):  
Punit Sharma ◽  
Sellam Karunanithi ◽  
Partha S. Chakraborty ◽  
Rajeev Kumar ◽  
Amlesh Seth ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Bone Metastasis ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Pet Ct ◽  
18F Fluoride
Sign in / Sign up

Export Citation Format

Share Document